Cognition Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -61 | -61 | -61 | -45 |
EBITDA | -13,610 | -4,869 | -6,670 | -8,430 |
EBIT | -13,671 | -4,930 | -6,731 | -8,475 |
Net Income | -3,343 | -4,930 | -6,734 | -8,480 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,437 | -5,651 | -5,623 | -9,877 |
Cash | 37,000 | 39,823 | 10,743 | 16,428 |
Basic Shares | 88,904 | 77,951 | 63,690 | 61,828 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -228 | -266 | -252 | -235 |
EBITDA | -47,799 | -33,680 | -25,509 | -21,134 |
EBIT | -48,027 | -33,946 | -25,761 | -21,369 |
Net Income | -23,487 | -33,971 | -25,788 | 757 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -13,158 | |||
Free Cash Flow | -24,588 | -28,478 | -16,165 | -18,704 |
Cash | 36,810 | 25,009 | 29,922 | 41,562 |
Basic Shares | 72,766 | 39,730 | 30,029 | 28,991 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.02 |
2025-09-30 | -$0.06 |
2025-06-30 | -$0.11 |
